BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 19 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 19 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 19 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 20 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 20 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 21 hours ago Atmus Welcomes Heath Sharp to Board of Directors 23 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 23 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 19 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 19 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 19 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 20 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 20 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 21 hours ago Atmus Welcomes Heath Sharp to Board of Directors 23 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 23 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT

Immunogen Inc. (IMGN) Q2 2020 Earnings Call Transcript

Immunogen Inc  (NASDAQ: IMGN) Q2 2020 earnings call dated July 31, 2020 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications and Investor Relations Mark Enyedy — President…

Market News

ImmunoGen (IMGN) Earnings: 2Q20 Key Numbers

ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period. Net loss was $24.3 million, or $0.14 per…

Market News

ImmunoGen Inc (IMGN): Q4 2019 Earnings Snapshot

— ImmunoGen Inc. (NASDAQ: IMGN) reported its fourth-quarter 2019 earnings of $0.03 per share vs $0.05 per share loss expected.   — Revenue jumped threefold to $44.8…